Answer Summary

Members expressed cautious optimism and hope about Moderna's HIV vaccine beginning human trials, with many viewing it as a promising step... Read more

Members expressed cautious optimism and hope about Moderna's HIV vaccine beginning human trials, with many viewing it as a promising step toward freedom from living with the virus. Several members asked practical questions about whether the vaccine could benefit those already living with HIV or only work as prevention for HIV-negative individuals, with clarification that current trials focus on prevention. A recurring theme was the community's deep longing for a cure rather than just a vaccine, balanced with gratitude that any progress brings them closer to that ultimate goal.